Gaja Alternative Asset Management IPO 2026: GMP, Price, Financials and Should You Apply?

The Gaja Alternative Asset Management IPO is attracting investor attention as the company enters the public market with a ₹550 crore mainboard issue. The IPO opened on August 19, 2026, and will close on August 21, 2026. The company has fixed the price band at ₹152–₹160 per share, with a lot size of 93 shares.

Gaja Alternative Asset Management Company Profile

Gaja Alternative Asset Management operates under the Gaja Capital brand and focuses on alternative asset management and private equity. The company manages and advises India-focused Category I and Category II Alternative Investment Funds (AIFs) and advises offshore funds investing in Indian businesses. Its investment focus includes sectors such as digital technology, consumer, financial services and education, mainly within India’s mid-market segment.

The company earns income by managing funds, providing investment advisory services and generating returns from its investment activities. Its long operating history and established investment platform support its business model.

Gaja Alternative IPO Dates, Price Band and Issue Size

Particulars	Details
IPO Open Date	August 19, 2026
IPO Close Date	August 21, 2026
Price Band	₹152–₹160 per share
Lot Size	93 shares
Minimum Investment	₹14,880
Fresh Issue	₹450 crore
Offer for Sale (OFS)	₹100 crore
Total Issue Size	₹550 crore
Expected Listing Date	August 26, 2026

Gaja Alternative Asset Management Financial Performance 

Metric	FY2024	FY2025	FY2026
Total Income	₹103.96 Cr	₹123.31 Cr	₹157.80 Cr
EBITDA	₹49.25 Cr	₹60.81 Cr	₹72.05 Cr
PAT	₹44.74 Cr	₹61.95 Cr	₹81.96 Cr
PAT Margin	43.04%	50.24%	51.94%

The company delivered strong profit growth in FY2026, supported by higher income and improved operating performance.

Gaja Alternative IPO GMP

The Gaja Alternative IPO GMP was recently reported around ₹25. At the ₹160 upper price band, this indicates an implied market price of around ₹185. However, GMP is unofficial and can change quickly. Investors should not use GMP as the sole basis for investment decisions.

Strengths

• Strong FY2026 profit growth.
• High PAT margin of around 52%.
• Established alternative investment platform.
• Low debt and healthy financial position.
• Growing opportunities in India’s private capital market.

Risks

• Earnings depend partly on investment and fund performance.
• Regulatory changes may affect the AIF industry.
• Competition from other asset managers remains high.
• Fundraising can slow during weak market conditions.
• Growth Prospects and Valuation

India’s expanding private capital market and growing demand for alternative investments could support Gaja’s future growth. At ₹160 per share, the IPO valuation needs to be compared with listed asset-management companies and the company’s future earnings potential.

Should Investors Apply?

The IPO may suit long-term investors with a higher risk appetite. Strong profitability, low debt and the growing alternative investment market are positive factors. However, investors should study the valuation, business risks and fund performance before applying.

Conclusion

The Gaja Alternative Asset Management IPO combines strong FY2026 profitability, an experienced investment platform and low leverage. Its growth prospects remain attractive as India’s alternative investment market expands. However, investors should focus on business fundamentals and valuation rather than relying only on GMP. For suitable long-term investors, the IPO can be considered, but it is not a risk-free investment.

FAQs

1. What is the Gaja Alternative IPO price band?

Ans: ₹152–₹160 per share.

2. What is the lot size?

Ans: 93 shares per lot.

3. What is the total issue size?

Ans: ₹550 crore.

4. What is the Gaja Alternative IPO GMP?

Ans: Recent reports indicated GMP of around ₹25, but it can change.

5. Should investors apply?

Ans: Long-term investors with higher risk appetite may consider the IPO after checking valuation and risks.

Disclaimer: This article is for informational purposes only and not investment advice. IPO details, GMP and market data may change. Investors should verify information before making investment decisions.